Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial) | MicrobiomeTrials← Back to trialsNCT07584083
Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-04-29Est. Completion: 2028-06
Enrollment target: 20 participants Locations- Laiko General Hospital, Athens, Greece, Greece
Other microbiome trials you might be interested in
Antiphospholipid Syndrome (APS)Thrombosis
This is a Phase I, open-label, dose escalation, multicenter study to evaluate the safety, tolerability, preliminary effi…
Beijing, ChinaEst. completion Sep 30, 2027
Antiphospholipid Syndrome
Antiphospholipid antibody syndrome (APS) is characterized by the presence of antiphospholipid antibodies, which are prot…
Durham, United StatesEst. completion Mar 2029